In cancer settings, CD14+ MDSCs have been shown to be the dominant suppressive populations of MDSCs, and correlated with cancer incidence, whereas G-MDSC did not correlate with clinical outcomes, even though both subsets were increased[21]. Here, CD14 is linked to cancer.